Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alejandra Ramírez-Venegas, Mónica Velázquez-Uncal, Adrián Aranda-Chávez, Nicolás Eduardo Guzmán-Bouilloud, María Eugenia Mayar-Maya, José Luis Pérez Lara-Albisua, Rafael de Jesus Hernández-Zenteno, Fernando Flores-Trujillo & Raúl H Sansores. (2019) Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1753-1762.
Read now
Read now
Nobuyuki Horita & Takeshi Kaneko. (2015) Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 813-822.
Read now
Read now
Andrea Rossi, Erika Zanardi, Venerino Poletti & Mario Cazzola. (2015) Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1383-1392.
Read now
Read now
Gaetano Caramori, Kian Fan Chung & Ian M Adcock. (2014) Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 249-256.
Read now
Read now
Paschalis Steiropoulos, Kostas Archontogeorgis, Evangelia Nena & Demosthenes Bouros. (2014) New developments in the management of COPD: clinical utility of indacaterol 75 μg. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1-7.
Read now
Read now
Annette J Theron, Helen C Steel, Gregory R Tintinger, Charles Feldman & Ronald Anderson. (2013) Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?. Drug Design, Development and Therapy 7, pages 1387-1398.
Read now
Read now
Articles from other publishers (9)
Deepak Timalsina, Krishna Prasad Pokhrel & Deepti Bhusal. (2021) Pharmacologic Activities of Plant-Derived Natural Products on Respiratory Diseases and Inflammations. BioMed Research International 2021, pages 1-23.
Crossref
Crossref
Yinghan Chan, Sin Wi Ng, Hui Shan Liew, Lesley Jia Wei Pua, Laura Soon, Jun Sing Lim, Kamal Dua & Dinesh Kumar Chellappan. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
47
84
.
Fabiano Di Marco, Pierachille Santus, Nicola Scichilone, Paolo Solidoro, Marco Contoli, Fulvio Braido & Angelo Guido Corsico. (2017) Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Respiratory Medicine 125, pages 49-56.
Crossref
Crossref
N. Sh. Zagidullin, Y. F. Safina, R. H. Zulkarneev, Y. G. Aznabaeva, G. M. Nurtdinova & Sh. Z. Zagidullin. (2016) CARDIOVASCULAR EFFECTS OF INDACATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. PULMONOLOGIYA 26:5, pages 570-577.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
357
381
.
Andrea P. Rossi, Erika Zanardi, Mauro Zamboni & Andrea Rossi. (2015) Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?. Drugs & Aging 32:9, pages 679-687.
Crossref
Crossref
Stefano Nardini, Gianna Camiciottoli, Salvatore Locicero, Rosario Maselli, Franco Pasqua, Giovanni Passalacqua, Riccardo Pela, Alberto Pesci, Alfredo Sebastiani & Alessandro Vatrella. (2014) COPD: maximization of bronchodilation. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Michael Salmon, Stacey L. Tannheimer, Terry T. Gentzler, Zhi‐Hua Cui, Eric A. Sorensen, Kimberly C. Hartsough, Musong Kim, Lafe J. Purvis, Edward G. Barrett, Jacob D. McDonald, Karin Rudolph, Melanie Doyle‐Eisele, Philip J. Kuehl, Christopher M. Royer, William R. Baker, Gary B. Phillips & Clifford D. Wright. (2014)
The in vivo efficacy and side effect pharmacology of
GS
‐5759, a novel bifunctional phosphodiesterase 4 inhibitor and long‐acting
β
2
‐adrenoceptor agonist in preclinical animal species
. Pharmacology Research & Perspectives 2:4.
Crossref
Crossref
Ronald Anderson, Annette J. Theron, Helen C. Steel, Chrisna Durandt, Gregory R. Tintinger & Charles Feldman. (2014)
The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils
In Vitro
. Mediators of Inflammation 2014, pages 1-9.
Crossref
Crossref